NUS Consumer Defensive

Nu Skin Enterprises, Inc.

$4.70-1.67%

Price as of close on Nov 3, 2026 · Financials updated Oct 10, 2026

Basics

Sector: Consumer Defensive
Industry: Household & Personal Products
Country: United States
Market cap: 228.8M USD
Enterprise value: 272.5M USD
Full-time employees: 2,800

Overall health

Drawback: less profitable than most peersless profitable than peers
Drawback: growing more slowly than most peersgrowing more slowly than peers
Drawback: higher risk than most peers: its share price swings more than most peers’ (beta 0.90 vs a peer median of 0.41), though less than the overall markethigher risk: bigger price swings (beta 0.90 vs peers 0.41)
About average: valuation

Ranks #687 of 761 consumer defensive companies (bottom 10%)

See how it ranks against its peers

Worth knowing

Profit growing, cash flow isn't. Profit +53% since 2022, operating cash flow −26%.
Nu Skin Enterprises's reported profit rose 53% since 2022, but the cash its operations generate changed −26%. When profit and cash diverge like this, it's worth understanding why (for example, customers paying more slowly or gains that aren't cash).Nu Skin Enterprises's reported profit rose 53% since 2022, but the cash its operations generate changed −26%. When profit and cash diverge like this, it's worth understanding why.
Stock pay outran buybacks. Stock-based pay expense $55M vs $33M spent repurchasing shares over the 3 fiscal years to 2025.
Over three fiscal years Nu Skin Enterprises recorded $55M of stock-based pay expense and spent $33M repurchasing shares (repurchases can include shares withheld to cover employees' taxes). Repurchases were smaller than the stock pay, so they did little to offset new employee shares.Over three fiscal years Nu Skin Enterprises recorded $55M of stock-based pay expense and spent $33M repurchasing shares. Repurchases were smaller than the stock pay, so they did little to offset new employee shares.
Earnings slid into a loss. Loss per share this year after a profit last year.
Nu Skin Enterprises made a loss per share in its latest year after a profit the year before.
Annual revenue fell three years running. Fiscal-year revenue down each year from 2022 to 2025.
Nu Skin Enterprises's fiscal-year revenue declined in each of the three years to 2025.

StockQuotient Score

24/ 100▼ 1 since Oct 27 close

Oct 5 24 → Nov 4 24

Valuation

Is the price right?

57/100

Moderate

3/3 inputs reported · High confidence

Since last quarter: No major changeValuation also moves with the share price every day.

Why

Mixed versus peers:

▲ EBITDA yield
▼ Earnings yield
▼ FCF yield

Compare with peers

Behind the score

Sector-normalized EBITDA, earnings, and free cash flow yields.

Earnings yield-94.6%

SEC filings · 12 months to Jun 2026Negative (a loss or cash outflow), so it counts as zero whatever the share price30% base weight · Z-score -1.51Sector median: 0.0453 · MAD: 0.0301

EBITDA yield15.5%

SEC filings · 12 months to Jun 2026Reported value50% base weight · Z-score 1.57Sector median: 0.0865 · MAD: 0.0435

Free cash flow yield4.7%

SEC filings · 12 months to Jun 2026 · operating cash flow − capital spendingReported value20% base weight · Z-score -0.34Sector median: 0.0622 · MAD: 0.0441

Other data (not scored)

Book yield237.2%

SEC filings · latest balance sheetOutlier capped at sector 5th/95th percentileInformational · 0% composite weightSector median: 0.5381 · MAD: 0.2865

Growth

Is it growing?

3/100

Weak

3/3 inputs reported · High confidence

Since last quarter: ▼ Weaker

12-month revenue fell 4.6%

Why

Weaker than most peers on:

▼ 3-yr revenue
▼ Revenue growth
▼ EPS growth

Compare with peers

Behind the score

Revenue and earnings-per-share growth over one year, and revenue growth over three years.

Earnings per share growthUnavailable

Earnings per share turned from a profit to a loss33% base weight · Z-score -2.08Sector median: 0.0154 · MAD: 0.2529

3-year revenue growth-12.3%

SEC filings · 3 years to Jun 2026Outlier capped at sector 5th/95th percentile33% base weight · Z-score -3.16Sector median: 0.0366 · MAD: 0.0470

Revenue growth-15.4%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score -3.11Sector median: 0.0278 · MAD: 0.0585

Profitability

Does it earn well?

8/100

Weak

3/3 inputs reported · High confidence

Since last quarter: ▼ Weaker

Turned to a loss over the last 12 months
Operating margin fell 6.3 points to -0.8%

Why

Weaker than most peers on:

▼ ROA
▼ Operating margin
▼ ROIC

Compare with peers

Behind the score

Return on invested capital, operating margin, and return on assets.

Operating margin-0.8%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score -1.64Sector median: 0.0759 · MAD: 0.0508

Return on assets-19.3%

SEC filings · 12 months to Jun 2026Outlier capped at sector 5th/95th percentile33% base weight · Z-score -3.62Sector median: 0.0396 · MAD: 0.0262

Return on invested capital-1.5%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score -1.35Sector median: 0.0766 · MAD: 0.0673

Other data (not scored)

Gross margin69.2%

SEC filings · 12 months to Jun 2026Outlier capped at sector 5th/95th percentileInformational · 0% composite weightSector median: 0.3182 · MAD: 0.1263

Return on equity-39.9%

SEC filings · 12 months to Jun 2026Outlier capped at sector 5th/95th percentileInformational · 0% composite weightSector median: 0.0831 · MAD: 0.0675

Risk

Debt, liquidity, price swings

Higher

Higher relative risk

3/3 inputs reported · High confidence

Since last quarter: ▼ Weaker

Operating profit now covers interest only 0.0x

Why it changed since the Oct 27, 2026 close: Safety percentile 31 → 30

Peer companies moved-1

Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.

Why

Weaker than most peers on:

▼ Beta

Compare with peers

Behind the score

Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.

Beta0.90

Yahoo Finance · 5-year monthly beta vs the marketReported value33% base weight · Z-score -2.92Sector median: 0.4070 · MAD: 0.1690

Current ratio1.98×

SEC filings · latest balance sheetReported value33% base weight · Z-score 0.71Sector median: 1.5250 · MAD: 0.6460

Debt / equity0.39×

SEC filings · latest balance sheetReported value33% base weight · Z-score 0.08Sector median: 0.4234 · MAD: 0.3581

Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.

Questions investors ask about Nu Skin Enterprises

Is Nu Skin Enterprises getting weaker?: Its latest SEC filing (Aug 10, 2026) got weaker in some ways: turned to a loss over the last 12 months; operating margin fell 6.3 points to -0.8%. Its overall score is 24/100, down 1 since Oct 28, 2026.
How is Nu Skin Enterprises valued vs its peers?: Priced about in line with its peers. Valuation scores 57/100 against 823 consumer defensive peers. EBITDA yield 15.5% vs a peer median of 8.7% (stronger than 81% of peers).EBITDA yield 15.5% vs peers 8.7% (stronger than 81% of peers). Earnings yield -94.6% vs a peer median of 4.5% (weaker than 100% of peers).Earnings yield -94.6% vs peers 4.5% (weaker than 100% of peers).
Is Nu Skin Enterprises growing?: More slowly than most of its peers. Growth scores 3/100 against 823 consumer defensive peers. 3-year revenue growth -12.3% vs a peer median of 3.7% (weaker than 100% of peers).3-year revenue growth -12.3% vs peers 3.7% (weaker than 100% of peers).
How profitable is Nu Skin Enterprises?: Less profitable than most of its peers. Profitability scores 8/100 against 823 consumer defensive peers. Return on assets -19.3% vs a peer median of 4.0% (weaker than 100% of peers).Return on assets -19.3% vs peers 4.0% (weaker than 100% of peers).
How risky is Nu Skin Enterprises?: Higher risk relative to 823 consumer defensive peers, judged on debt, liquidity and share-price swings. Current ratio 1.98× vs a peer median of 1.52× (stronger than 65% of peers).Current ratio 1.98× vs peers 1.52× (stronger than 65% of peers). Beta 0.90 vs a peer median of 0.41 (weaker than 90% of peers).Beta 0.90 vs peers 0.41 (weaker than 90% of peers). A relative measure, not a bankruptcy probability.

Latest filing: what changed

Quarter ended Jun 30, 2026 · filed Aug 10, 2026 · compared with the quarter ended Mar 31, 2026

Got weaker

Turned to a loss over the last 12 months
Operating margin fell 6.3 points to -0.8%
12-month revenue fell 4.6%
Operating profit now covers interest only 0.0x

Worth watching: Nu Skin Enterprises is in the bottom fifth of its sector on profitability. From 2021 to 2025, 63% of companies in that position posted a loss over the following year, against 4% for the top fifth.

	Previous quarter	Latest quarter	Change
Revenue (12 months)	1.4B USD	1.4B USD	−4.6%
Net income (12 months)	54.5M USD	−216.4M USD	turned negative
Operating margin	5.5%	-0.8%	−6.3 pts
Free cash flow (12 months)	41.6M USD	10.8M USD	−74.1%
Debt	223.6M USD	213.7M USD	−4.4%
Cash	198.7M USD	189.6M USD	−4.5%
Shares outstanding	48.6M	48.7M	+0.3%

From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.

Industry valuation context

Sector: Consumer Defensive · 91 companies

Valuations in Consumer Defensive are within their usual range since 2016.

30% of months since 2016 were valued lower than now.
18% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values −4% and earnings +7% (medians): prices and earnings moved broadly together.
Median price-to-sales is −58% vs the whole market, against a usual −39%.

2016Shaded: most expensive fifth of its range2026

Shown for Consumer Defensive: too few Household & Personal Products companies have a long enough history of their own.

Financials

Fiscal years from SEC annual filings · change vs the prior year

Key ratios	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Change
Gross margin	75.0%	71.7%	68.9%	68.2%	69.4%	▲ 1.2 pts
Operating margin	8.7%	5.0%	2.5%	-8.8%	4.4%	▲ 13 pts
Net margin	5.5%	4.7%	0.4%	-8.5%	10.8%	▲ 19 pts
Return on assets (ROA)	7.7%	5.8%	0.5%	-10.0%	11.4%	▲ 21 pts
Return on equity (ROE)	16.1%	11.7%	1.0%	-22.5%	19.9%	▲ 42 pts
Free cash flow margin	2.7%	2.2%	3.1%	4.1%	3.1%	▼ 1.0 pts
Current ratio	1.65×	2.12×	2.13×	1.82×	2.08×	▲ 14%
Quick ratio	0.89×	1.15×	1.28×	1.17×	1.40×	▲ 19%
Debt to equity	0.41×	0.45×	0.61×	0.60×	0.28×	▼ 54%
Interest coverage	21.27×	8.21×	1.89×	-5.74×	4.71×	▲ 182%

NUS price history

Price history is added with the daily price update and will appear after the next one.

Similar companies

Sector leaderboards

Chin Teck Plantations Berhad1929.KL94/ 100

First Resources LimitedEB5.SI91/ 100

Sipef NVSIP.BR91/ 100

Bringing the fundamentals into focus…

Overall health

Drawback: less profitable than most peersless profitable than peers

Drawback: growing more slowly than most peersgrowing more slowly than peers

Drawback: higher risk than most peers: its share price swings more than most peers’ (beta 0.90 vs a peer median of 0.41), though less than the overall markethigher risk: bigger price swings (beta 0.90 vs peers 0.41)

About average: valuation

Ranks #687 of 761 consumer defensive companies (bottom 10%)

See how it ranks against its peers

Worth knowing

Profit growing, cash flow isn't. Profit +53% since 2022, operating cash flow −26%.

Nu Skin Enterprises's reported profit rose 53% since 2022, but the cash its operations generate changed −26%. When profit and cash diverge like this, it's worth understanding why (for example, customers paying more slowly or gains that aren't cash).Nu Skin Enterprises's reported profit rose 53% since 2022, but the cash its operations generate changed −26%. When profit and cash diverge like this, it's worth understanding why.

Stock pay outran buybacks. Stock-based pay expense $55M vs $33M spent repurchasing shares over the 3 fiscal years to 2025.

Over three fiscal years Nu Skin Enterprises recorded $55M of stock-based pay expense and spent $33M repurchasing shares (repurchases can include shares withheld to cover employees' taxes). Repurchases were smaller than the stock pay, so they did little to offset new employee shares.Over three fiscal years Nu Skin Enterprises recorded $55M of stock-based pay expense and spent $33M repurchasing shares. Repurchases were smaller than the stock pay, so they did little to offset new employee shares.

Earnings slid into a loss. Loss per share this year after a profit last year.

Nu Skin Enterprises made a loss per share in its latest year after a profit the year before.

Annual revenue fell three years running. Fiscal-year revenue down each year from 2022 to 2025.

Nu Skin Enterprises's fiscal-year revenue declined in each of the three years to 2025.

Questions investors ask about Nu Skin Enterprises

Is Nu Skin Enterprises getting weaker?

Its latest SEC filing (Aug 10, 2026) got weaker in some ways: turned to a loss over the last 12 months; operating margin fell 6.3 points to -0.8%. Its overall score is 24/100, down 1 since Oct 28, 2026.

How is Nu Skin Enterprises valued vs its peers?

Priced about in line with its peers. Valuation scores 57/100 against 823 consumer defensive peers. EBITDA yield 15.5% vs a peer median of 8.7% (stronger than 81% of peers).EBITDA yield 15.5% vs peers 8.7% (stronger than 81% of peers). Earnings yield -94.6% vs a peer median of 4.5% (weaker than 100% of peers).Earnings yield -94.6% vs peers 4.5% (weaker than 100% of peers).

Is Nu Skin Enterprises growing?

More slowly than most of its peers. Growth scores 3/100 against 823 consumer defensive peers. 3-year revenue growth -12.3% vs a peer median of 3.7% (weaker than 100% of peers).3-year revenue growth -12.3% vs peers 3.7% (weaker than 100% of peers).

How profitable is Nu Skin Enterprises?

Less profitable than most of its peers. Profitability scores 8/100 against 823 consumer defensive peers. Return on assets -19.3% vs a peer median of 4.0% (weaker than 100% of peers).Return on assets -19.3% vs peers 4.0% (weaker than 100% of peers).

How risky is Nu Skin Enterprises?

Higher risk relative to 823 consumer defensive peers, judged on debt, liquidity and share-price swings. Current ratio 1.98× vs a peer median of 1.52× (stronger than 65% of peers).Current ratio 1.98× vs peers 1.52× (stronger than 65% of peers). Beta 0.90 vs a peer median of 0.41 (weaker than 90% of peers).Beta 0.90 vs peers 0.41 (weaker than 90% of peers). A relative measure, not a bankruptcy probability.

Previous quarter

Latest quarter

Change

Revenue (12 months)

1.4B USD

1.4B USD

−4.6%

Net income (12 months)

54.5M USD

−216.4M USD

turned negative

Operating margin

5.5%

-0.8%

−6.3 pts

Free cash flow (12 months)

41.6M USD

10.8M USD

−74.1%

Debt

223.6M USD

213.7M USD

−4.4%

Cash

198.7M USD

189.6M USD

−4.5%

Shares outstanding

48.6M

48.7M

+0.3%

Key ratios

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Change

Gross margin

75.0%

71.7%

68.9%

68.2%

69.4%

▲ 1.2 pts

Operating margin

8.7%

5.0%

2.5%

-8.8%

4.4%

▲ 13 pts

Net margin

5.5%

4.7%

0.4%

-8.5%

10.8%

▲ 19 pts

Return on assets (ROA)

7.7%

5.8%

0.5%

-10.0%

11.4%

▲ 21 pts

Return on equity (ROE)

16.1%

11.7%

1.0%

-22.5%

19.9%

▲ 42 pts

Free cash flow margin

2.7%

2.2%

3.1%

4.1%

3.1%

▼ 1.0 pts

Current ratio

1.65×

2.12×

2.13×

1.82×

2.08×

▲ 14%

Quick ratio

0.89×

1.15×

1.28×

1.17×

1.40×

▲ 19%

Debt to equity

0.41×

0.45×

0.61×

0.60×

0.28×

▼ 54%

Interest coverage

21.27×

8.21×

1.89×

-5.74×

4.71×

▲ 182%